Medicare Enrolled
Dr. Ramsay Kuo, MD
Urology Physician · Venice, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kuo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kuo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kuo
Dr. Ramsay Kuo is an urology physician in Venice, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kuo performed 5,385 Medicare services across 2,641 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kuo received a total of $10,433 from 38 pharmaceutical and/or device companies across 267 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kuo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 23% volume in FL
$10,433 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,385
Medicare services
Top 23% in FL for urology physician
2,641
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~269 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
2,065 | $5 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,003 | $65 | $151 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
485 | $2 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
425 | $88 | $219 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
385 | $7 | $38 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
215 | $114 | $333 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
145 | $180 | $454 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
99 | $40 | $91 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
77 | $74 | $217 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
46 | $19 | $51 |
| Laser prostate fragmentation with bleeding control This procedure uses a laser to break up prostate tissue and control bleeding through an endoscope. |
39 | $642 | $1,891 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
38 | $54 | $190 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
28 | $235 | $726 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
28 | $97 | $506 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
27 | $310 | $882 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
26 | $270 | $620 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
26 | $147 | $374 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
26 | $56 | $148 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
25 | $25 | $368 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
25 | $24 | $120 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $123 | $294 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $103 | $283 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
20 | $294 | $637 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
19 | $47 | $234 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
19 | $5 | $157 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
18 | $66 | $158 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
16 | $97 | $1,270 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
12 | $84 | $235 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
47.6% medium
50.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,433
Total received (2018-2024)
Avg $1,490/year across 7 years
Top 20% in FL for urology physician
38
Companies
267
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,234 (50.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,487 (43.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$713 (6.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$464
2023
$693
2022
$608
2021
$227
2020
$5,722
2019
$1,076
2018
$1,643
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$5,333
Astellas Pharma US Inc
$1,199
Janssen Biotech, Inc.
$499
PFIZER INC.
$455
NeoTract Inc.
$327
ABBVIE INC.
$287
Travere Therapeutics, Inc.
$188
Endo Pharmaceuticals Inc.
$182
PROCEPT BioRobotics Corporation
$151
Sumitomo Pharma America, Inc.
$151
Coloplast Corp
$145
180 Medical, Inc.
$138
AbbVie, Inc.
$132
TOLMAR Pharmaceuticals, Inc.
$115
Janssen Products, LP
$99
Bayer HealthCare Pharmaceuticals Inc.
$92
Avadel Specialty Pharmaceuticals, LLC
$85
Allergan Inc.
$83
Laborie Medical Technologies Corp.
$81
Rochester Medical Corporation
$74
Antares Pharma, Inc.
$72
Retrophin, Inc.
$61
DENTSPLY IH Inc.
$59
Stryker Corporation
$47
Teleflex LLC
$44
Axonics, Inc.
$43
Novartis Pharmaceuticals Corporation
$39
AbbVie Inc.
$36
Merck Sharp & Dohme LLC
$34
C. R. Bard, Inc. & Subsidiaries
$33
Myovant Sciences Inc.
$28
Metuchen Pharmaceuticals
$26
GlaxoSmithKline, LLC.
$22
UroGen Pharma, Inc.
$20
Medtronic, Inc.
$17
Mission Pharmacal Company
$15
Ferring Pharmaceuticals Inc.
$12
C. R. BARD, INC. & SUBSIDIARIES
$11
Top 3 companies account for 67.4% of total payments
Associated products mentioned in payments ›
(815) Thiola · 1688 · ALTIS · AQUABEAM SYSTEM · AVEED · Androgel · AquaBeam Robotic System · Axonics · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · CONTINENCE CARE · DORMIA N. STONE · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL - KIDNEY STONE DISEASE · GENTLECATH · GentleCath · INTERSTIM · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Moses 550 DFL · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · SHINGRIX · SPEEDICATH · SWISS LITHOCLAST TRILOGY · SpeediCath · Stendra · Thiola · UROLIFT · Urgent PC Neuromodulation System · UroLift · Urocit-K · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (50%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $194 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
34
Per 100K population
7.6
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL - VENICE
6.4 mi
6.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kuo is a clinical cardiology specialist, with above-average Medicare volume (top 23% in FL), with consulting-driven industry engagement in the top 20% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kuo experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Kuo performed 2,065 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kuo receive payments from pharmaceutical companies?
Yes. Dr. Kuo received a total of $10,433 from 38 companies across 267 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kuo's costs compare to other urology physicians in Venice?
Dr. Kuo's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kuo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Venice
Browse urology physicians in Venice ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology